Czech Version of the Autonomic Scale for Outcomes in Parkinson’s Disease (SCOPA-AUT) – Questionnaire to Assess the Presence and Severity of Autonomic Dysfunction in Patients with Parkinson’s Disease

Czech version

Authors: M. Kaiserová ¹; J. Opavský ²; J. J. Maertin ³; D. J. Gaul ⁴; M. Bareš ⁵; M. Baláž ⁵; J. Roth ⁶; P. Kaňovský ¹
Authors‘ workplace: Centrum pro diagnostiku a léčbu neurodegenerativních onemocnění, Neurologická klinika LF UP a FN Olomouc ¹; Katedra fyzioterapie, Fakulta tělesné kultury UP v Olomouci ²; Katedra společenských věd v kinantropologii, Fakulta tělesné kultury UP v Olomouci ³; Translation & Interpreting, Olomouc ⁴; I. neurologická klinika LF MU a FN u sv. Anny v Brně ⁵; Neurologická klinika 1. LF UK a VFN v Praze ⁶
Published in: Cesk Slov Neurol N 2014; 77/110(1): 96-99
Category: Short Communication

Overview

Autonomic nervous system dysfunctions are common non-motor symptoms in patients with Parkinson’s disease. It is important to search for these symptoms as they may be present even at early stages of the disease and may have a significant impact on the quality of life. Nevertheless, there is no valid and reliable questionnaire in Czech language to identify these symptoms. The aim of our research was to translate (according to the Movement Disorder Society recommendations) a questionnaire to assess the presence of autonomic dysfunction in the patients with Parkinson’s disease.

Key words:
Parkinson’s disease – autonomic dysfunction – questionnaire

The authors declare they have no potential conflicts of interest concerning drugs, products, or services used in the study.

The Editorial Board declares that the manuscript met the ICMJE “uniform requirements” for biomedical papers.

Sources

1. Parkinson J. An essay on the shaking palsy. London: Sherwood, Neely and Jones 1817.

2. Chaudhuri KR, Healy DG, Schapira AH; National Institute for Clinical Excellence. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 2006; 5(3): 235–245.

3. Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson’s disease. Mov Disord 2001; 16(3): 507–510.

4. Gaig C, Tolosa E. When does Parkinson’s disease begin? Mov Disord 2009; 24 (Suppl 2): S656–S664.

5. Simuni T, Sethi K. Nonmotor manifestations of Parkinson’s disease. Ann Neurol 2008; 64 (Suppl 2): S65–S80.

6. Farnikova K, Krobot A, Kanovsky P. Musculoskeletal problems as an initial manifestation of Parkinson’s disease: a retrospective study. J Neurol Sci 2012; 319(1–2): 102–104.

7. Müller B, Larsen JP, Wentzel-Larsen T, Skeie GO, Tysnes OB; Parkwest Study Group. Autonomic and sensory symptoms and signs in incident, untreated Parkinson’s disease: frequent but mild. Mov Disord 2011; 26(1): 65–72.

8. Jost WH. Autonomic dysfunctions in idiopathic Parkinson’s disease. J Neurol 2003; 250 (Suppl 1): I28–I30.

9. Awerbuch GI, Sandyk R. Autonomic functions in the early stages of Parkinson’s disease. Int J Neurosci 1994; 74(1–4): 9–16.

10. Berrios GE, Campbell C, Politynska BE. Autonomic failure, depression and anxiety in Parkinson’s disease. Br J Psychiatry 1995; 166(6): 789–792.

11. Magerkurth C, Schnitzer R, Braune S. Symptoms of autonomic failure in Parkinson’s disease: prevalence and impact on daily life. Clin Auton Res 2005; 15(2): 76–82.

12. Visser M, Marinus J, Stiggelbout AM, Van Hilten JJ. Assessment of autonomic dysfunction in Parkinson’s disease: the SCOPA-AUT. Mov Disord 2004; 19(11): 1306–1312.

13. Takahashi A. Autonomic nervous system disorders in Parkinson’s disease. Eur Neurol 1991; 31 (Suppl 1): 41–47.

14. Evatt ML, Chaudhuri KR, Chou KL, Cubo E, Hinson V, Kompoliti K et al. Dysautonomia rating scales in Parkinson’s disease: sialorrhea, dysphagia, and constipation – critique and recommendations by movement disorders task force on rating scales for Parkinson’s disease. Mov Disord 2009; 15; 24(5): 635–646.

15. Pavy-Le Traon A, Amarenco G, Duerr S, Kaufmann H, Lahrmann H, Shaftman SR et al. The Movement Disorders task force review of dysautonomia rating scales in Parkinson’s diseasewith regard to symptoms of orthostatic hypotension. Mov Disord 2011; 26(11): 1985–1992.

16. Task force of Movement Disorder Society. Drugs to treat autonomic dysfunction in Parkinson’s disease. Mov Disord 2002; 17 (Suppl 4): S103–S111.

17. Wild D, Grove A, Martin M, Eremenco S, McElroy S, Verjee-Lorenz A et al; ISPOR Task Force for Translation and Cultural Adaptation. Principles of Good Practice for the Translation and Cultural Adaptation Process for Patient-Reported Outcomes (PRO) Measures: report of the ISPOR Task Force for Translation and Cultural Adaptation. Value Health 2005; 8(2): 94–104.